Pamiparib Plus Surufatinib in Patients With Platinum-resistant Ovarian Cancer
Conditions
- Ovarian Cancer
- Ovarian Carcinoma
- Platinum-resistant Ovarian Cancer
- Fallopian Tube Carcinosarcoma
- Primary Peritoneal Cancer
Interventions
- DRUG: Pamiparib
- DRUG: Surufatinib
Sponsor
Sun Yat-sen University
Collaborators